Gossamer Bio Inc (OQ:GOSS)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for GOSS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 24th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 28/24 Mar 27/24 Christian Waage Direct Ownership Common Stock S - Open market or private sale -6,430 $1.16
Mar 28/24 Mar 27/24 Giraudo Bryan Direct Ownership Common Stock S - Open market or private sale -6,430 $1.16
Mar 28/24 Mar 27/24 Hasnain Faheem Direct Ownership Common Stock S - Open market or private sale -23,172 $1.16
Mar 19/24 Mar 18/24 Aranda Richard Direct Ownership Common Stock S - Open market or private sale -4,018 $1.33
Mar 19/24 Mar 18/24 Peterson Caryn Direct Ownership Common Stock S - Open market or private sale -4,018 $1.33
Mar 12/24 Mar 11/24 Drynan Skye Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 230,000  
Mar 12/24 Mar 11/24 Nathan Steven D Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 230,000  
Jan 4/24 Jan 2/24 Peterson Caryn Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 375,000  
Jan 4/24 Jan 2/24 Christian Waage Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 375,000  
Jan 4/24 Jan 2/24 Aranda Richard Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 487,500  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for GOSS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 24th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 28/24 Mar 27/24 Christian Waage Direct Ownership Common Stock S - Open market or private sale -6,430 $1.16
Mar 28/24 Mar 27/24 Giraudo Bryan Direct Ownership Common Stock S - Open market or private sale -6,430 $1.16
Mar 28/24 Mar 27/24 Hasnain Faheem Direct Ownership Common Stock S - Open market or private sale -23,172 $1.16
Mar 19/24 Mar 18/24 Aranda Richard Direct Ownership Common Stock S - Open market or private sale -4,018 $1.33
Mar 19/24 Mar 18/24 Peterson Caryn Direct Ownership Common Stock S - Open market or private sale -4,018 $1.33
Mar 12/24 Mar 11/24 Drynan Skye Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 230,000  
Mar 12/24 Mar 11/24 Nathan Steven D Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 230,000  
Jan 4/24 Jan 2/24 Peterson Caryn Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 375,000  
Jan 4/24 Jan 2/24 Christian Waage Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 375,000  
Jan 4/24 Jan 2/24 Aranda Richard Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 487,500  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $GOSS

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Medpace Holdings (OQ:MEDP)
United Therapeutics (OQ:UTHR)
Disc Medicine (OQ:IRON)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.